Sorex araneus (European shrew): 101539340
Help
Entry
101539340 CDS
T07854
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
sara
Sorex araneus (European shrew)
Pathway
sara01524
Platinum drug resistance
sara04010
MAPK signaling pathway
sara04115
p53 signaling pathway
sara04148
Efferocytosis
sara04210
Apoptosis
sara04215
Apoptosis - multiple species
sara04623
Cytosolic DNA-sensing pathway
sara04650
Natural killer cell mediated cytotoxicity
sara04657
IL-17 signaling pathway
sara04668
TNF signaling pathway
sara04726
Serotonergic synapse
sara04932
Non-alcoholic fatty liver disease
sara04933
AGE-RAGE signaling pathway in diabetic complications
sara04936
Alcoholic liver disease
sara05010
Alzheimer disease
sara05012
Parkinson disease
sara05014
Amyotrophic lateral sclerosis
sara05016
Huntington disease
sara05020
Prion disease
sara05022
Pathways of neurodegeneration - multiple diseases
sara05132
Salmonella infection
sara05133
Pertussis
sara05134
Legionellosis
sara05145
Toxoplasmosis
sara05146
Amoebiasis
sara05152
Tuberculosis
sara05160
Hepatitis C
sara05161
Hepatitis B
sara05162
Measles
sara05163
Human cytomegalovirus infection
sara05164
Influenza A
sara05165
Human papillomavirus infection
sara05167
Kaposi sarcoma-associated herpesvirus infection
sara05168
Herpes simplex virus 1 infection
sara05169
Epstein-Barr virus infection
sara05170
Human immunodeficiency virus 1 infection
sara05200
Pathways in cancer
sara05203
Viral carcinogenesis
sara05205
Proteoglycans in cancer
sara05206
MicroRNAs in cancer
sara05210
Colorectal cancer
sara05222
Small cell lung cancer
sara05416
Viral myocarditis
sara05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
sara00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
101539340 (CASP3)
04668 TNF signaling pathway
101539340 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
101539340 (CASP3)
09143 Cell growth and death
04210 Apoptosis
101539340 (CASP3)
04215 Apoptosis - multiple species
101539340 (CASP3)
04115 p53 signaling pathway
101539340 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
101539340 (CASP3)
04650 Natural killer cell mediated cytotoxicity
101539340 (CASP3)
04657 IL-17 signaling pathway
101539340 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
101539340 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
101539340 (CASP3)
05206 MicroRNAs in cancer
101539340 (CASP3)
05205 Proteoglycans in cancer
101539340 (CASP3)
05203 Viral carcinogenesis
101539340 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
101539340 (CASP3)
05222 Small cell lung cancer
101539340 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
101539340 (CASP3)
05161 Hepatitis B
101539340 (CASP3)
05160 Hepatitis C
101539340 (CASP3)
05164 Influenza A
101539340 (CASP3)
05162 Measles
101539340 (CASP3)
05168 Herpes simplex virus 1 infection
101539340 (CASP3)
05163 Human cytomegalovirus infection
101539340 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
101539340 (CASP3)
05169 Epstein-Barr virus infection
101539340 (CASP3)
05165 Human papillomavirus infection
101539340 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
101539340 (CASP3)
05133 Pertussis
101539340 (CASP3)
05134 Legionellosis
101539340 (CASP3)
05152 Tuberculosis
101539340 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
101539340 (CASP3)
05145 Toxoplasmosis
101539340 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
101539340 (CASP3)
05012 Parkinson disease
101539340 (CASP3)
05014 Amyotrophic lateral sclerosis
101539340 (CASP3)
05016 Huntington disease
101539340 (CASP3)
05020 Prion disease
101539340 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
101539340 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
101539340 (CASP3)
05416 Viral myocarditis
101539340 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
101539340 (CASP3)
04932 Non-alcoholic fatty liver disease
101539340 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
101539340 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
101539340 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
sara01002
]
101539340 (CASP3)
Enzymes [BR:
sara01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
101539340 (CASP3)
Peptidases and inhibitors [BR:
sara01002
]
Cysteine peptidases
Family C14: caspase family
101539340 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Erf4
Motif
Other DBs
NCBI-GeneID:
101539340
NCBI-ProteinID:
XP_004610417
LinkDB
All DBs
Position
Unknown
AA seq
276 aa
AA seq
DB search
MENSEISVDAKSVKNSEVKVIHGSKSVDSGIALDNSYKMDYPEMGVCLIINNKNFKGQGM
STRTGTDVDAARLKETFTNLKYEVRIKNDLTCEEIMKLLHSASLEDHSKRSSFICVFLSH
GEEGTIFGTDKPIELKILAGFFRGDCCRTLTGKPKIFIIQACRGTELDCGIETDSGSESD
MTCQKIPVEADFLYAYSTAPGYYSWRNSKEGSWFIQSLCDILKQYADKLEFMHILTRVNQ
KVATEFESYSLDITFHAKKQIPCIMSMLTKELYFYH
NT seq
831 nt
NT seq
+upstream
nt +downstream
nt
atggagaactctgaaatctcagtggatgcgaaatccgtaaagaattcagaagtgaaggtc
attcatggcagcaagtcggtggactctggaatagccttggacaacagttacaaaatggac
tatcctgaaatgggcgtgtgtttaataattaataataagaactttaaaggccaaggaatg
tcgactcggactggtacagatgtagatgcagcaagactcaaggaaacatttactaacttg
aaatacgaagtcaggatcaaaaatgatcttacctgtgaggaaattatgaaattgctgcac
agcgcttctttagaagatcatagcaaaaggagcagttttatttgtgtgtttttaagccat
ggtgaagaaggaactatttttggaacagataaacctattgagctgaagatcttagcaggt
tttttcagaggagattgttgcagaactctaactggaaaaccgaaaattttcattattcag
gcctgccgaggtacagaactcgactgtggaatagagactgacagtggttctgagagtgac
atgacgtgtcagaagattccggtggaagctgacttcttgtatgcgtattctacagcacct
ggttactattcttggcgaaattcaaaggaaggatcctggttcattcagtcactttgtgat
atattgaagcagtacgctgacaaacttgagttcatgcacattcttactcgggtcaaccaa
aaggtagcaacagaatttgagtcctattctctggatataactttccacgcgaagaagcag
attccatgtattatgtctatgctcacaaaagaactgtatttttatcactga
DBGET
integrated database retrieval system